摘要
目的:膀胱癌发生发展的分子机制尚不清楚。膀胱癌是流行病学研究和了解临床意义的重要焦点。 目标:预防的主要目的是通过限制非遗传风险因素的暴露来实现,如吸烟、饮食、饮用水中的砷或工作场所或其他地方的芳香胺。目前膀胱癌的治疗受到肿瘤形态和相关获得性基因突变的影响。 方法:使用PubMed、Scopus、ResearchGate、谷歌、MEDLINE和ScienceDirect数据库进行文献检索,查找1984年至2020年初发表的膀胱癌研究。重点是关于流行病学风险因素和潜在的病理生理机制的文章。选择的文章使我们能够回顾这些因素以及分子和结构模式。 结果:膀胱癌有多种观点。这些文献提供了一些关于膀胱癌发展和进展的新见解,以及可能在临床和诊断实践中有用的生物标志物。结论:膀胱癌的分子途径有多种,且不断更新。此外,膀胱肿瘤的基因亚型还不清楚,需要进一步的详细分析。
关键词: 膀胱癌,膀胱癌发病机制,危险因素,NMIBC, MIBC,膀胱癌分子途径,膀胱癌组织学分类,免疫组化,PD-L1。
Current Medicinal Chemistry
Title:Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns
Volume: 28 Issue: 41
关键词: 膀胱癌,膀胱癌发病机制,危险因素,NMIBC, MIBC,膀胱癌分子途径,膀胱癌组织学分类,免疫组化,PD-L1。
摘要:
Objective: The molecular mechanisms of bladder cancer development and progression are not clear. Bladder cancer is an important focus for epidemiological studies and understanding clinical implications.
Goal: The primary aim of prevention is achieved by limiting exposure to non-genetic risk factors, such as smoking, diet, arsenic in drinking water, or aromatic amines at work or elsewhere. Current therapies for bladder cancer are affected by tumor morphology and associated acquired genetic mutations.
Methods: A literature search was performed using PubMed, Scopus, ResearchGate, Google, MEDLINE, and ScienceDirect databases to find studies of bladder cancer published between 1984 and early 2020. The focus was articles that address epidemiological risk factors and underlying pathophysiological mechanisms. Articles were selected that enabled our review of these factors as well as molecular and structural patterns.
Results: There are multiple views of bladder cancer. The literature offers several novel insights regarding the development and progression of bladder cancer and possible biomarkers that may be useful in clinical and diagnostic practice.
Conclusion: There are several molecular pathways associated with bladder cancer that are frequently updated. In addition, genetic subtypes of bladder tumors are not distinguished clearly which requires future more detailed analysis.
Export Options
About this article
Cite this article as:
Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns, Current Medicinal Chemistry 2021; 28 (41) . https://dx.doi.org/10.2174/0929867328666210309111731
DOI https://dx.doi.org/10.2174/0929867328666210309111731 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-diabetic Glucose levels and Cancer Mortality: A Literature Review
Current Diabetes Reviews TRICOM Vector Based Cancer Vaccines
Current Pharmaceutical Design Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
Current Cancer Drug Targets Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics
Current Molecular Pharmacology ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents
Current Cancer Drug Targets Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation
Current Drug Targets New Directions for Clinical Trials of Targeted Alpha Therapy for Metastatic Melanoma
Current Radiopharmaceuticals Structure and Regulation of the Drug-Metabolizing Enzymes Arylamine N-acetyltransferases
Current Medicinal Chemistry Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Current Gene Therapy Thermodynamic and Kinetic Aspects Involved in the Development of Nanocarriers and Drug Delivery Systems Based on Cationic Biopolymers
Current Pharmaceutical Design Discovery of New Inhibitors of Urease Enzyme: A Study Using STD-NMR Spectroscopy
Letters in Drug Design & Discovery PET Measurements of cAMP-Mediated Phosphodiesterase-4 with (R)-[11C]Rolipram
Current Radiopharmaceuticals The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons
Current Medicinal Chemistry Current Gene Expression Studies in Esophageal Carcinoma
Current Genomics Lipid-based Nanocarriers As An Alternative for Oral Delivery of Poorly Water- Soluble Drugs: Peroral and Mucosal Routes
Current Medicinal Chemistry The Potentials of Selected Therapeutic Targets for Inflammation: A Snapshot
Recent Patents on Inflammation & Allergy Drug Discovery Squalamine as an Example of a New Potent Antimicrobial Agents Class: A Critical Review
Current Medicinal Chemistry Mutant B-Raf Kinase Inhibitors as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Hypoxia Responsive Drug Delivery Systems in Tumor Therapy
Current Pharmaceutical Design